Previous 10 | Next 10 |
Company Enters the Multi-Billion Dollar CBD Market with Proprietary Instrument System Designed to Significantly Improve the Processing of CBD Oil into High Quality, Water-Soluble Nanoemulsions SOUTH EASTON, MA / ACCESSWIRE / July 25, 2019 / Pressure BioSciences, I...
Pressure BioSciences (OTCQB: PBIO) , a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced its entry into a contract services agreement with a multi-billion biotherapeutics company ...
Company Expects Significant Services Revenue Increase in 2019 as it Expands its BaroFold Platform into the Estimated $44 Billion Global Bioprocess Technology Market SOUTH EASTON, MA / ACCESSWIRE / July 24, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the &...
Pressure BioSciences (OTCQB: PBIO) , a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, this morning announced that its flagship Barocycler 2320EXTREME was prominently featured at a three-day, i...
Scientists from the Elite Westlake University Report on the Use of the PCT Platform to Significantly Improve the Preparation of Clinical Laboratory Specimens for Evaluation SOUTH EASTON, MA / ACCESSWIRE / July 18, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and th...
PBIO’s proprietary Ultra Sheer Technology (“UST”) platform can be used to create the higher quality, more nutritious, longer-lasting, chemical-free foods that consumers demand Recent delivery of a working benchtop UST instrument to Ohio State scientists marks the firs...
Pressure BioSciences (OTCQB: PBIO) , a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences industry, recently announced that its patented pressure cycling technology (“PCT”) platform was featured in 15 ind...
PBIO’s proprietary Ultra Shear Technology (UST) platform achieves the long sought-after ability to create truly water-soluble CBD oil that can provide optimized solubility and bioavailability for CBD absorption As a result of the long sought-after demand for safe and effective wate...
Pressure BioSciences (OTCQB: PBIO) , a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences industry, this morning announced the launch of its BaroShear(TM) K45 system based on PBIO’s proprietary Ultra Shear Techn...
Purchase Deposits for the New BaroShear K45 System Will be Accepted Immediately; Company Believes Sales into the CBD Market Could Double Current Revenue by Q2 2020 SOUTH EASTON, MA / ACCESSWIRE / June 27, 2019 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a le...
News, Short Squeeze, Breakout and More Instantly...
Pressure BioSciences Inc Company Name:
PBIO Stock Symbol:
OTCMKTS Market:
Pressure BioSciences Inc Website:
Pressure BioSciences (OTCQB: PBIO) , a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemulsion products and services across global industries, today announced a partnership with Vita-Forte, the larg...
CANTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemul...
Pressure BioSciences (OTCQB: PBIO) , a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, today announced that it will host a teleconference to update investors an...